FANAX | VENAX | FANAX / VENAX | |
Total Expense Ratio | 0.98 | 0.09 | 1,089% |
Annual Report Gross Expense Ratio | 0.98 | 0.09 | 1,089% |
Fund Existence | 29 years | 21 years | - |
Gain YTD | 7.745 | 2.971 | 261% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 952M | 9B | 11% |
Annual Yield % from dividends | 0.88 | 3.07 | 29% |
Returns for 1 year | 10.32 | 5.25 | 196% |
Returns for 3 years | 23.23 | 10.65 | 218% |
Returns for 5 years | 242.88 | 190.75 | 127% |
Returns for 10 years | 82.15 | 40.39 | 203% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FCEF | 22.84 | N/A | N/A |
First Trust Income Opportunity ETF | |||
MAYP | 30.11 | N/A | N/A |
PGIM S&P 500 Buffer 12 ETF - May | |||
KNO | 50.79 | -0.13 | -0.25% |
AXS Knowledge Leaders ETF | |||
VSDA | 53.83 | -0.43 | -0.80% |
VictoryShares Dividend Accelerator ETF | |||
BMEZ | 14.23 | -0.14 | -0.97% |
BlackRock Health Sciences Term Trust |